Silencing of B7-H3 Increases Gemcitabine Sensitivity by Promoting Apoptosis in Pancreatic Carcinoma

Oncology Letters - Greece
doi 10.3892/ol.2013.1118
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

B7-H3 Combats Apoptosis Induced by Chemotherapy by Delivering Signals to Pancreatic Cancer Cells

Oncotarget
Oncology
2017English

Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine

Clinical Cancer Research
Cancer ResearchOncology
2004English

B7-H3 Silencing by RNAi Inhibits Tumor Progression and Enhances Chemosensitivity in U937 Cells

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

B7-H3 Silencing Inhibits Tumor Progression of Mantle Cell Lymphoma and Enhances Chemosensitivity

International Journal of Oncology
Cancer ResearchOncology
2015English

Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling

Scientific Reports
Multidisciplinary
2015English

Cyclopentenyl Cytosine Increases Gemcitabine Radiosensitisation in Human Pancreatic Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2008English

The Contrasting Role of B7-H3

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

B7-H3 in Cancer – Beyond Immune Regulation

Trends in Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy